Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melphalan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01660633
What this trial is testing

Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation

Who this might be right for
Multiple Myeloma
Acrotech Biopharma Inc. 61
Testing effectiveness (Phase 2)Study completedNCT00536978
What this trial is testing

Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies

Who this might be right for
LymphomaLeukemia
M.D. Anderson Cancer Center 22
Early research (Phase 1)Active Not RecruitingNCT02909036
What this trial is testing

Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.

Who this might be right for
Multiple MyelomaAmyloidosis
Memorial Sloan Kettering Cancer Center 46
Not applicableStudy completedNCT02474563
What this trial is testing

Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Korea, Ltd., Korea 171
Testing effectiveness (Phase 2)Ended earlyNCT02295722
What this trial is testing

GEMHDM2014 : Gem-HDM HDT and ASCT for Relapsed/ Refractory Lymphoma

Who this might be right for
Hodgkin's Lymphoma - Relapsed/RefractoryNon-Hodgkin's Lymphoma - AggressiveFollicular Lymphoma
AHS Cancer Control Alberta 100
Testing effectiveness (Phase 2)UnknownNCT01342237
What this trial is testing

Tandem High Dose Chemotherapy and Autologous Stem Cell Rescue for High Risk Pediatric Brain Tumors

Who this might be right for
Brain Tumors
Seoul National University Hospital 33
Testing effectiveness (Phase 2)Study completedNCT00027560
What this trial is testing

Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Memorial Sloan Kettering Cancer Center 51
Testing effectiveness (Phase 2)Looking for participantsNCT07281924
What this trial is testing

Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis

Who this might be right for
Metastatic MelanomaLiver Metastases
University of Wisconsin, Madison 15
Large-scale testing (Phase 3)Study completedNCT00205751
What this trial is testing

Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy

Who this might be right for
Multiple Myeloma
Austrian Forum Against Cancer 350
Large-scale testing (Phase 3)Study completedNCT00949039
What this trial is testing

Study Comparing Isolated Pelvic Perfusion With TNF-α 0.3 mg and Melphalan 1.5 mg/kg Versus Standard Treatment in Patients With Non Resectable, Recurrent Gynaecologic or Digestive Pelvic Cancer

Who this might be right for
Gynaecologic or Digestive Pelvic Cancer
Gustave Roussy, Cancer Campus, Grand Paris 101
Early research (Phase 1)Study completedNCT00005792
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
H. Lee Moffitt Cancer Center and Research Institute 131
Testing effectiveness (Phase 2)Study completedNCT00744536
What this trial is testing

Efficacy Study of Revlimid® and Low Dose Continuously Administered Melphalan to Treat High Risk MDS

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicAngiogenesis
Sunnybrook Health Sciences Centre 20
Testing effectiveness (Phase 2)Study completedNCT00505895
What this trial is testing

FM 140 vs FM100 Study in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center 52
Large-scale testing (Phase 3)Study completedNCT01916252
What this trial is testing

Bortezomib (Velcade®), Lenalidomide (Revlimid®) and IV Busulfan (Busilvex®) in Patients Under 65 Years Old

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 460
Early research (Phase 1)Study completedNCT01998971
What this trial is testing

JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 240
Testing effectiveness (Phase 2)Study completedNCT00629798
What this trial is testing

Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid LeukemiaAdvanced Myelodysplastic Syndromes
Memorial Sloan Kettering Cancer Center 64
Testing effectiveness (Phase 2)Study completedNCT00003416
What this trial is testing

S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Lymphoma
SWOG Cancer Research Network 9
Testing effectiveness (Phase 2)Ended earlyNCT02994784
What this trial is testing

Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients

Who this might be right for
Amyloidosis; Systemic
Boston Medical Center 27
Testing effectiveness (Phase 2)Looking for participantsNCT07582172
What this trial is testing

Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia With Complex KaryotypeMyelodysplastic Chronic Myelomonocytic LeukemiaMyelodysplastic Syndrome+8 more
City of Hope Medical Center
Large-scale testing (Phase 3)Study completedNCT00477971
What this trial is testing

Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 89
Next Page
35